reminyl xl 8 mg prolonged-release capsules, hard
takeda pharmaceuticals international ag ireland branch - galantamine hydrobromide - prolonged-release capsule, hard - 8 milligram(s) - anticholinesterases; galantamine
reminyl xl 16 mg prolonged-release capsules, hard
originalis b.v. - galantamine - prolonged-release capsule, hard - 16 milligram(s) - galantamine
reminyl xl 24 mg prolonged-release capsules, hard
originalis b.v. - galantamine - prolonged-release capsule, hard - 24 milligram(s) - anticholinesterases; galantamine
reminyl xl 8 mg prolonged-release capsules, hard
shire pharmaceuticals ireland limited - galantamine hydrobromide - capsule, hard - 8 milligram(s) - anticholinesterases; galantamine
reminyl xl 24 mg prolonged-release capsules
ltt pharma limited - galantamine - prolonged-release capsule - 24 milligram(s) - anticholinesterases; galantamine
apo-galantamine mr galantamine (as hydrobromide) 16 mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; hypromellose; titanium dioxide; magnesium stearate; microcrystalline cellulose; ethylcellulose; gelatin - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
apo-galantamine mr galantamine (as hydrobromide) 24 mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: erythrosine; ethylcellulose; titanium dioxide; iron oxide yellow; hypromellose; magnesium stearate; iron oxide red; gelatin; microcrystalline cellulose; indigo carmine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
apo-galantamine mr galantamine (as hydrobromide) 8 mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: titanium dioxide; microcrystalline cellulose; hypromellose; ethylcellulose; gelatin; magnesium stearate - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
reminyl xl 16 mg prolonged-release capsules
ltt pharma limited - galantamine hydrobromide - prolonged-release capsule - 16 milligram(s) - anticholinesterases; galantamine
galantax xl 16 milligram prolonged release capsules
clonmel healthcare ltd - galantamine hydrobromide - prolonged release capsules - 16 milligram